Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma

Published:2011-03-31 Issue:1 Volume:11 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Yeh Chau-Ting,Chen Hui-Chin,Sung Chang-Mu,Hsu Cheng-Lung,Lin Chen-Chun,Pan Kuang-Tse,Tseng Jeng-Hwei,Hung Chien-Fu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-11-117.pdf

Reference24 articles.

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-6. 10.1002/ijc.1440.

2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45: 529-38. 10.1016/j.jhep.2006.05.013.

3. Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Ishibashi H: Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer. 1992, 51: 509-14. 10.1002/ijc.2910510402.

4. Sherman M: Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005, 25: 143-54. 10.1055/s-2005-871194.

5. Kaido T, Uemoto S: Recent evidence in the treatment of small hepatocellular carcinoma. Hepatogastroenterology. 2008, 55: 1460-2.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib;Cancer Biomarkers;2023-04-06

2. A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-01-14

3. A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy;The Pharmacogenomics Journal;2019-10-14

4. The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma;Journal of Cancer;2019

5. A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib;Asia-Pacific Journal of Clinical Oncology;2018-05-21